Is Business Broken?
Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Sponsors in this episode
No sponsor reads found in this episode's notes.
Host-read ads that the notes don't mention can't be found this way.
Show notes
Last week's episode introduced the promises and challenges brought forth by Cell and Gene Therapies. Today's show dives deeper into this topic with BU Questrom Professor Rena Conti, an expert on the financing and regulation of the biopharmaceutical market.
She and host Curt Nickisch discuss why these treatments are so expensive, challenges for insurance companies, and potential solutions to ensure fair access.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
From the show's RSS feed.